← Back to Search

Electrical Stimulation

Electrical Stimulation for Stroke

N/A
Waitlist Available
Led By Sheng Li, MD, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke)
Has post stroke ≥ 6 months, medically stable
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 5 minutes after intervention
Awards & highlights

Study Summary

This trial will test a new electrical stimulation method to see if it can reduce spasticity and improve hand function in people who have had a stroke.

Who is the study for?
This trial is for individuals who have had a stroke at least 6 months ago, are medically stable, and have some muscle stiffness in their fingers. They must not be pregnant or adjusting medications for muscle tone, and cannot have visual, hearing or cognitive impairments, pacemakers, or a history of lung diseases like asthma or COPD.Check my eligibility
What is being tested?
The study is testing the effectiveness of Breathing-controlled electrical stimulation (BreEStim) compared to regular electrical stimulation (EStim) on reducing finger stiffness and improving hand function in people with moderate impairment after a stroke.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site of electrical stimulation, skin irritation from electrode placement, fatigue due to therapy sessions, and possible exacerbation of existing spasticity if the treatment does not work as intended.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had one stroke, regardless of its type or size.
Select...
I had a stroke more than 6 months ago and am now medically stable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 5 minutes after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 5 minutes after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)
Secondary outcome measures
Change in finger extensors and hand function measured by Fugl Myer Assessment (FMA) Scale

Trial Design

2Treatment groups
Experimental Treatment
Group I: EStimExperimental Treatment1 Intervention
EStim is transcutaneous electrical nerve stimulation.
Group II: BreEStimExperimental Treatment1 Intervention
BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BreEStim
2015
N/A
~20

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
902 Previous Clinical Trials
321,117 Total Patients Enrolled
3 Trials studying Motor Recovery
22 Patients Enrolled for Motor Recovery
Sheng Li, MD, PhD4.896 ReviewsPrincipal Investigator - University of Texas
Swedish Medical Center / First Hill Campus, Swedish Medical Center / Cherry Hill Campus, Swedish Medical Center / Issaquah Campus
Medical School - Rosalind Franklin University of Medicine and Science, Doctor of Medicine
Louisiana State University, Residency in Ophthalmology
8 Previous Clinical Trials
97 Total Patients Enrolled
2 Trials studying Motor Recovery
8 Patients Enrolled for Motor Recovery
4Patient Review
I appreciated his candour and the way he put my mind at ease. He explained that if nothing seems amiss, I wouldn't need to come back for a general eye exam for a few years. It's refreshing to have a doctor who isn't just interested in my money. The only drawback is that they don't do contact lens exams.

Media Library

BreEStim (Electrical Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT04750551 — N/A
Motor Recovery Research Study Groups: BreEStim, EStim
BreEStim (Electrical Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04750551 — N/A
Motor Recovery Clinical Trial 2023: BreEStim Highlights & Side Effects. Trial Name: NCT04750551 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has this clinical experiment begun recruiting participants?

"Based on the information listed in clinicaltrials.gov, this medical study is no longer actively recruiting patients. Initially posted on August 2nd 2022 and last updated April 23rd 2022, although not currently seeking applicants, there are 5 alternative trials that require participants."

Answered by AI

Does the enrollment for this experimental research extend to senior citizens?

"In accordance with the requirements of this clinical trial, only patients aged between 18 and 75 can be enrolled."

Answered by AI

Is there any potential for me to contribute to this medical experiment?

"To be a suitable enrollee in this study, individuals must fall between 18 and 75 years old while exhibiting motor recovery. Additionally, they should have a MAS score of 1 or above (signifying detectable finger flexor hypertonia). Finally, their stroke diagnosis needs to be unilateral and single-sided with no restrictions on type or volume."

Answered by AI
~3 spots leftby Sep 2024